Managing Director Address

• The presentation focused on capital markets, capital allocation, and strategy.
• The company emphasized its financial discipline and ability to fund its own development cycles.
• The company plans to invest in new technologies and markets to drive future growth.

Clinuvel Pharmaceuticals Ltd's Managing Director's presentation at the Annual General Meeting covered three main themes: capital markets, capital allocation, and strategy. The discussion highlighted the company's financial discipline, its ability to fund its own development cycles, and its strategy of concentric expansion. The company aims to invest in new technologies and markets to drive future growth, focusing on areas like peptide chemistry, polymer chemistry, and clinical applications.

Clinuvel Pharmaceuticals Ltd plans to continue investing in new technologies and markets to drive future growth, emphasizing its strategy of concentric expansion and financial discipline.